Multifunctional applications of hydrogel materials in myocardial infarction treatment: from tissue repair to microenvironment regulation.
作者信息
Zhang Hong, Song Junhuai, Chang Yunhe, Zheng Bin
机构信息
Department of Biochemistry and Molecular Biology, Key Laboratory of Neural and Vascular Biology, Ministry of Education, Hebei Key Laboratory of Cardiovascular Homeostasis and Aging, Hebei Medical University Shijiazhuang 050017 China
Department of Traumatic Orthopedics, Handan Central Hospital Handan 056000 China
出版信息
RSC Adv. 2025 Sep 2;15(38):31564-31585. doi: 10.1039/d5ra05286f. eCollection 2025 Aug 29.
Myocardial infarction (MI) is one of the leading causes of heart failure and death worldwide. While conventional treatments have limitations in promoting myocardial repair and regeneration, hydrogel, as a multifunctional biomaterial, shows great potential in MI treatment due to its unique physicochemical properties and biocompatibility. This paper reviews the multifunctional applications of hydrogels in MI therapeutics, including drug delivery (miRNAs, exosomes, ), electrical conduction, immunomodulation, detection, tissue engineering, and microfluidic functions. In terms of drug delivery, hydrogels are able to precisely deliver drugs, stem cells and exosomes to improve the microenvironment of the infarcted area through their controlled release properties. In the field of electrical conduction, hydrogels are used as scaffolding materials that mimic the mechanical and electrical properties of myocardial tissues. The role of hydrogels in immunomodulation has also attracted much attention. In addition, the application of hydrogels in biosensing and detection functions provides new strategies for real-time monitoring of MI. In summary, hydrogels have demonstrated multifunctional advantages in MI therapy, but their clinical applications still face challenges, such as the long-term biocompatibility of the materials and the feasibility of large-scale production. Future research should focus on optimizing the design of hydrogels for more precise treatment and wider applications.
相似文献
Front Cell Dev Biol. 2025-7-25
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2025-7-17
Tissue Eng Part B Rev. 2025-8-7
Arch Ital Urol Androl. 2025-6-30
2025-1
2025-1
Cochrane Database Syst Rev. 2020-1-9
本文引用的文献
ACS Appl Mater Interfaces. 2025-3-12
Biosens Bioelectron. 2025-5-15
Microsyst Nanoeng. 2025-1-9